Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Apr 3 2020;21(7)doi:10.3390/ijms21072484 Apolinario-Hagen J, Druge M, Fritsche L
R., & ATTAIN-1 Trial Investigators (2025)
As the scientific community delves further into this area, additional transporters regulating other critical metabolites may be uncovered, broadening the landscape of potential therapeutic targets
Closes the cortisol and nervous-system pathway that keeps the flushing going (HPA-axis pattern)
Methods Comparative network pharmacology effectiveness analysis of DM2 DMTs in preventing AD comorbidity in DM2 Reconstruction of the DM2-AD pathway-pathway comorbidity network To assess the therapeutic potential of DM2 DMTs in preventing comorbid AD in DM2, we first reconstructed the DM2-AD pathway-pathway comorbidity network, following an established methodology from previous work 19
doi: 10.1007/s00464-009-0652-7
US$ 28.52
US$ 24.62
US$ 22.91
US$ 21.05
